Text Size

Three-year follow-up of a novel aqueous humor microshunt

Batlle J.F., Fantes F., Riss I., Pinchuk L., Alburquerque R., Kato Y.P., Arrieta E., Peralta A.C., Palmberg P., Parrish R.K., II, Weber B.A., Parel J.-M.


  • 2016
  • Journal of Glaucoma
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Centro Laser, Santo Domingo, Dominican Republic; Ophthalmic Biophysics Center Bascom Palmer Eye Institute, University of MiamiMiller School of Medicine, United States; Anne Bates Leach Eye Hospital, University of Miami, United States; InnFocus Inc., Miami, FL, United States; Pôle Ophtalmologique de la Clinique Mutualiste, Pessac, Cedex, France

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.


Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.


The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022